The last results of the SORT OUT V submitted in PCR 2012 showed that biolimus eluting stent with biodegradable polymer was not able to reach the non-inferiority versus sirolimus eluting stent with permanent polymer.
Results to 3 years are now available, and the new device reached the non-inferiority with a MACE rate of 11.2% for biodegradable polymer stent versus 10.1% for the permanent polymer (p = 0.41) are now displayed. Stroke rates were also similar (3.7% versus 3.5%, P = 0.73), stent thrombosis (1.4% versus 1%, p = 0.45) and target vessel revascularization (6.6% versus 7%, P = 0.69).
Conclusion
No significant differences between the biodegradable polymer stent the stent permanently versus the permanent polymer stent at 3 years were observed.
E. Christiansen
2014-05-22
Title: DESSOLVE II trial results: 2-year follow-up of a crystalline sirolimus-eluting stent with rapid bioabsorbable polymer
